DRBP
Timeline
29 events since 2013Board
Filings
Financial
Establishments
Address
Other
2014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 25 days before the deadline
2025
Equity above €5m equity €5.4m ▲7.8% With a profit in every financial year since 2013, equity grows to €5.4m.
Annual accounts 2024 filed PDFabbreviated format · 6 days before the deadline
2024
Liquidity more than doubled current ratio 38.28 The current ratio rises from 17.82 to 38.28. Short-term debt falls from €252,091 to €133,374.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0502692701
Annual accounts 2023 filed PDFabbreviated format · 5 days late
2023
Highest result from 2013 to 2025 net €964,191 ▲18.8% The operating result of €1.4m and the net result of €964,191 are both a record.
Annual accounts 2022 filed PDFabbreviated format · 24 days late
2022
Company renamed from DOKTER ,KLINISCH BIOLOOG to DRBPAppointment: (director) · “De uitoefening van de geneeskunde,meer bepaald de KLINISCHE BIOLOGIE,door de geneesheren-aandeelhouders in…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 14-10-20226 points ▸
- General meeting, 14-10-2022
- Name change, DRBP
- 186 shares
- Director appointment, (director (not named in the articles))
- Registered office clause, Grote Hemmenweg 48, 3520 Zonhoven
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- The deed holds 6 more points.
Annual accounts 2021 filed PDFabbreviated format · 72 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 32 days before the deadline
2020
Equity above €2m equity €2.2m ▲41.6% With a profit in every financial year since 2013, equity grows to €2.2m.
Annual accounts 2019 filed PDFmicro format · 57 days before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 12 days before the deadline
2018
Liquidity more than doubled current ratio 22.20 The current ratio rises from 7.97 to 22.20. Short-term debt falls from €109,570 to €55,953.
Equity above €1m equity €1.2m ▲55.3% With a profit in every financial year since 2013, equity grows to €1.2m.
Annual accounts 2017 filed PDFmicro format · 34 days before the deadline
2017
Equity above €500,000 equity €763,981 ▲64% With a profit in every financial year since 2013, equity grows to €763,981.
Annual accounts 2016 filed PDFmicro format · 30 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 31 days late
2015
Liquidity more than triples current ratio 8.21 The current ratio rises from 2.69 to 8.21. Short-term debt falls from €42,395 to €31,431.
Equity above €200,000 equity €237,403 ▲172% With a profit in every financial year since 2013, equity grows to €237,403.
Annual accounts 2014 filed PDFabbreviated format · 29 days late
2014
Liquidity more than doubled current ratio 2.69 The current ratio rises from 0.94 to 2.69. Short-term debt falls from €48,296 to €42,395.
Registered office moved from Zandhoven to ZonhovenNew registered office: Grote Hemmenweg 48 te 3520 Zonhoven · Previous registered office: Vogelzandstraat 51, 2240 Zandhoven1 point ▸
- Registered-office move, Grote Hemmenweg 48 te 3520 Zonhoven
- The deed holds 1 more point.
Director in office: (manager)1 point ▸
- Director in office, (manager)
Annual accounts 2013 filed PDFabbreviated format · 54 days before the deadline
2013
Incorporation PDFpublished on 05-02-2013
First establishment At the time the registered office was still in Zandhoven, Vogelzandstraat 51.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank